---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-24-001130"
form_type: "8-K"
ticker: "TNON"
cik: "0001560293"
company_name: "Tenon Medical, Inc."
filed_at: "2024-07-25T23:59:59+00:00"
generated_at: "2026-05-31T16:17:02.709941+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tenon Medical shareholders approve director elections, equity plan amendment, and Series B terms at 2024 annual meeting

## Summary
- All seven director nominees elected with majority support; broker non-votes ~1.2M shares.
- Shareholders approved Series B Preferred Stock terms and warrant issuance; vote 2,391,579 for, 45,130 against.
- 2022 Equity Incentive Plan amended to add 1,100,000 shares; approved 2,318,386 for, 117,137 against.
- Haskell & White LLP ratified as independent auditor for FY2024; 3,609,093 for, 11,604 against.
- Adjournment proposal approved to solicit additional proxies if needed; 2,720,153 for.

## SEC filing metadata
- accession: 0001013762-24-001130
- form_type: 8-K
- ticker: TNON
- cik: 0001560293
- company_name: Tenon Medical, Inc.
- filed_at: 2024-07-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1560293/000101376224001130/0001013762-24-001130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1560293/000101376224001130/ea0209964-8k_tenon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-24-001130
- JSON: https://secwatch.observer/filing/0001013762-24-001130.json
- Plain text: https://secwatch.observer/filing/0001013762-24-001130.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.